RI
RTW Investments’s Avidity Biosciences RNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $273M | Buy |
9,618,845
+871,919
| +10% | +$24.8M | 3.89% | 9 |
|
|
2025
Q1 | $258M | Buy |
8,746,926
+814,056
| +10% | +$24M | 3.95% | 8 |
|
|
2024
Q4 | $231M | Sell |
7,932,870
-200,000
| -2% | -$5.82M | 3.49% | 6 |
|
|
2024
Q3 | $374M | Sell |
8,132,870
-673,968
| -8% | -$31M | 5.4% | 3 |
|
|
2024
Q2 | $360M | Buy |
8,806,838
+836,569
| +10% | +$34.2M | 5.57% | 4 |
|
|
2024
Q1 | $203M | Buy |
7,970,269
+1,280,480
| +19% | +$32.7M | 3% | 11 |
|
|
2023
Q4 | $60.5M | Hold |
6,689,789
| – | – | 0.95% | 30 |
|
|
2023
Q3 | $42.7M | Hold |
6,689,789
| – | – | 0.9% | 30 |
|
|
2023
Q2 | $74.2M | Buy |
6,689,789
+302,611
| +5% | +$3.36M | 1.41% | 23 |
|
|
2023
Q1 | $98M | Buy |
6,387,178
+781,612
| +14% | +$12M | 2.04% | 19 |
|
|
2022
Q4 | $124M | Buy |
5,605,566
+434,782
| +8% | +$9.65M | 2.54% | 15 |
|
|
2022
Q3 | $84.4M | Buy |
5,170,784
+375,784
| +8% | +$6.14M | 1.95% | 18 |
|
|
2022
Q2 | $69.7M | Hold |
4,795,000
| – | – | 1.8% | 18 |
|
|
2022
Q1 | $88.6M | Hold |
4,795,000
| – | – | 1.83% | 22 |
|
|
2021
Q4 | $114M | Hold |
4,795,000
| – | – | 1.66% | 19 |
|
|
2021
Q3 | $118M | Buy |
4,795,000
+800,000
| +20% | +$19.7M | 1.78% | 17 |
|
|
2021
Q2 | $98.7M | Hold |
3,995,000
| – | – | 1.49% | 23 |
|
|
2021
Q1 | $87.1M | Hold |
3,995,000
| – | – | 1.36% | 26 |
|
|
2020
Q4 | $102M | Hold |
3,995,000
| – | – | 1.71% | 16 |
|
|
2020
Q3 | $110M | Hold |
3,995,000
| – | – | 2.65% | 11 |
|
|
2020
Q2 | $104M | Buy |
+3,995,000
| New | +$104M | 2.92% | 9 |
|